Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging
PET reveals ‘smoldering’ brain inflammation in patients treated for MS
By
Will Morton
PET brain scans show persistent brain inflammation in patients with multiple sclerosis (MS), despite being treated with therapies.
April 29, 2024
Dual-tracer PET/CT shows promise in liver cancer patients
By
Will Morton
Dual-tracer PET/CT appears valuable for improving tumor staging in patients with hepatocellular carcinoma being evaluated for treatment.
April 26, 2024
SPECT/CT predicts foot amputations in diabetics
By
Will Morton
Technetium-99m white blood cell SPECT/CT imaging may be useful for identifying diabetic patients at risk of amputations due to foot infections.
April 24, 2024
PET/CT superior to MRI for detecting spinal bone metastases
By
Will Morton
Gallium-68 DOTATATE PET/CT appears to be the best approach for detecting spinal bone metastases in patients with certain neuroendocrine tumors.
April 23, 2024
Neuroimaging detects blast exposure brain injuries in U.S. soldiers
By
Will Morton
A battery of MRI and PET neuroimaging tests show patterns of brain injury in active-duty U.S. soldiers caused by repeated blast exposures.
April 22, 2024
PET/MRI reveals sex differences in patients with autism
By
Will Morton
PET/MRI shows that young women with autism spectrum disorder have increased brain metabolism associated with translocator protein.
April 18, 2024
PET tracer for gliomas under expedited review
By
AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to Telix Pharmaceuticals’ PET radiotracer F-18 floretyrosine (Pixclara) for imaging progressive or recurring gliomas.
April 17, 2024
FAPI-PET shows promise in patients with lung cancer
By
Will Morton
FAPI-PET imaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans.
April 15, 2024
Vision transformer AI model boosts PET/CT imaging of cancer
By
Will Morton
A vision transformer AI model outperformed convolutional neural networks when classifying tumors on PET/CT images as benign or malignant.
April 12, 2024
Can AI improve sustainability in nuclear medicine?
Nuclear medicine experts support the use of AI to improve sustainability of practices in the field, yet say implementation will require careful consideration of the technology’s benefits and detriments.
April 9, 2024
PET/MRI detects brain injury in pediatric cancer survivors
By
Will Morton
PET/MRI could be a tool for diagnosing brain injury due to high-dose methotrexate treatment in young cancer survivors.
April 8, 2024
Life Molecular Imaging, Sofie add Neuraceq availability out of Ohio
By
AuntMinnie.com staff writers
Life Molecular Imaging and Sofie Biosciences have begun offering the Neuraceq PET radiotracer produced at Sofie's radiopharmaceutical manufacturing site in Cleveland, Ohio.
April 5, 2024
Page 1 of 593
Next Page